Literature DB >> 19695135

Portuguese version of the Quality of Life Enjoyment and Satisfaction Questionnaire: a validation study.

Carlos Zubaran1, Katia Foresti, Mariana Rossi Thorell, Paulo Roberto Franceschini, Wagner Homero.   

Abstract

OBJECTIVE: The aim of this study was to demonstrate the validity and reliability of the Portuguese version of the Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q) among substance users in southern Brazil.
METHODS: The original English version of the Q-LES-Q was translated into Portuguese taking into account semantic and conceptual equivalence. The Portuguese versions of the Q-LES-Q and the World Health Organization Quality of Life Instrument (WHOQOL-BREF) were used to assess quality of life among crack cocaine and inhalant users. Factorial and reliability analyses as well as correlation studies were conducted to establish the psychometric properties of the Portuguese version of the Q-LES-Q.
RESULTS: All areas of the Q-LES-Q achieved significant Cronbach's coefficients. Significant Pearson correlation coefficients were obtained between various subscales of the Q-LES-Q and the four dimensions of the WHOQOL-BREF. Correlations were significant when crack and inhalant users were analyzed separately or conjointly. Inhalant users presented significantly higher scores than crack users in the social (p=0.035) and general (p=0.005) subscales of the Q-LES-Q.
CONCLUSION: The Portuguese version of the Q-LES-Q possesses sound internal validity. The English version of the Q-LES-Q was adequately adapted to Portuguese. Inhalant users may present lower levels of satisfaction with social life and overall quality of life than crack users. The Portuguese version of the Q-LES-Q is a reliable questionnaire for future research and clinical use with substance users in Brazil.

Entities:  

Mesh:

Year:  2009        PMID: 19695135     DOI: 10.1590/s1020-49892009000500010

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  6 in total

1.  The application of the Drug User Quality of Life Scale (DUQOL) in Australia.

Authors:  Carlos Zubaran; Jonathan Emerson; Rishi Sud; Elham Zolfaghari; Katia Foresti
Journal:  Health Qual Life Outcomes       Date:  2012-03-18       Impact factor: 3.186

2.  Cross-cultural measurement invariance of the Quality of Life Enjoyment and Satisfaction Questionnaire-Short form across ten countries: the application of Bayesian approximate measurement invariance.

Authors:  Zahra Bagheri; Parisa Chamanpara; Peyman Jafari; Yatan Pal Singh Balhara; Sidharth Arya; Ramdas Ransing; Ana Đorić; Rajna Knez; Tuong-Vi Vu Thi; Truong Ngoc Huong; Helin Yilmaz Kafali; Gamze Erzin; Zahir Vally; Mita Rani Roy Chowdhury; Pawan Sharma; Rabi Shakya; Luís Antônio Monteiro Campos; Anna Rebeka Szczegielniak; Dejan Stevanović
Journal:  BMC Psychol       Date:  2022-06-24

3.  Validity and reliability of the Chinese version of the Short Form of Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-SF).

Authors:  Yun-Tse Lee; Shen-Ing Liu; Hui-Chun Huang; Fang-Ju Sun; Chiu-Ron Huang; Albert Yeung
Journal:  Qual Life Res       Date:  2013-09-24       Impact factor: 4.147

4.  Butcher's quality of life evaluation with the WHOQOL-bref.

Authors:  Julianne Cristine Ferreira; Vivian Urbanejo Romero; Rogério Muniz de Andrade; Eduardo Costa Sá
Journal:  Rev Bras Med Trab       Date:  2017-09-01

5.  Psychometric Properties of the Malay-Language Quality of Life Enjoyment and Satisfaction Scale: A Confirmatory Study on Malaysian Children.

Authors:  Mohamad Fadil Ibrahim; Garry Kuan; Hairul Anuar Hashim; Nurul Azuar Hamzah; Yee Cheng Kueh
Journal:  Int J Environ Res Public Health       Date:  2021-01-13       Impact factor: 3.390

6.  Factor structure of the Q-LES-Q short form in an enrolled mental health clinic population.

Authors:  Rachel P Riendeau; Jennifer L Sullivan; Mark Meterko; Kelly Stolzmann; Alicia K Williamson; Christopher J Miller; Bo Kim; Mark S Bauer
Journal:  Qual Life Res       Date:  2018-09-04       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.